Financhill
Back

Milestone Pharmaceuticals Vs. Agios Pharmaceuticals Industry Stock Comparison

Sell
47

MIST
Milestone Pharmaceuticals

Last Price:
$2.04
Seasonality Move:
-23.25%
Sell
17

AGIO
Agios Pharmaceuticals

Last Price:
$35.34
Seasonality Move:
1.61%
Sell
47
Milestone Pharmaceuticals (MIST) is a Sell

Is Milestone Pharmaceuticals a Buy, Sell or Hold?

  • The current Milestone Pharmaceuticals [MIST] share price is $1.99. The Score for MIST is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
  • MIST is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
17
Agios Pharmaceuticals (AGIO) is a Sell

Is Agios Pharmaceuticals a Buy, Sell or Hold?

  • The current Agios Pharmaceuticals [AGIO] share price is $34.06. The Score for AGIO is 17, which is 66% below its historic median score of 50, and infers higher risk than normal.
  • AGIO is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

MIST Stock Price Chart

What is Milestone Pharmaceuticals's stock price today?

  • The Milestone Pharmaceuticals share price today is $1.99
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MIST is experiencing selling pressure, which indicates risk of future bearish movement.

AGIO Stock Price Chart

What is Agios Pharmaceuticals's stock price today?

  • The Agios Pharmaceuticals share price today is $34.06
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AGIO is experiencing slight buying pressure.

MIST Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.03 Buy
Relative Strength Index (14 RSI): 49.39 Sell
Chaikin Money Flow: -936552 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.82 - 2.18) Sell
Bollinger Bands (100): (1.46 - 1.96) Buy

AGIO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.88 Sell
Relative Strength Index (14 RSI): 40.21 Sell
Chaikin Money Flow: 236200 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (32.07 - 37.73) Sell
Bollinger Bands (100): (36.91 - 52.97) Sell

MIST Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 2.01 Sell
20-day SMA: 2.06 Sell
50-day SMA: 1.93 Buy
200-day SMA: 1.62 Buy
8-day EMA: 2.03 Sell
20-day EMA: 2.02 Sell
50-day EMA: 1.91 Buy
200-day EMA: 1.81 Buy

AGIO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 33.36 Buy
20-day SMA: 33.7 Buy
50-day SMA: 45.11 Sell
200-day SMA: 42.46 Sell
8-day EMA: 33.44 Buy
20-day EMA: 35.38 Sell
50-day EMA: 40.47 Sell
200-day EMA: 41.04 Sell

Milestone Pharmaceuticals Earnings Growth & MIST Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.20 per share, and an increase next year of $0.95 per share.

Agios Pharmaceuticals Earnings Growth & AGIO Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $9.62 per share, a decrease next quarter of $0.00 per share, a decrease this year of $17.01 per share, and an increase next year of $0.63 per share.

Milestone Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Agios Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):